Avalanche is a gene therapy company committed to discovering and developing novel medicines that can offer life-changing therapeutic benefit to patients dealing with chronic or debilitating disease.
Avalanche Biotechnologies and Annapurna Therapeutics Announce Proposed Merger
Avalanche Biotechnologies, Inc. Names Paul B. Cleveland as CEO
Avalanche Biotechnologies, Inc. Reports Third Quarter 2015 Financial Results
Avalanche Biotechnologies & Annapurna Therapeutics Announce Proposed Merger
Read Press Release